No abstract

A57 tive pulmonary diseases, asthma, coronary artery disease, diabetes, obesity, liver, or thyroid condition, cancer and stroke). Ordinary least square regression (OLS) and multinomial logistic regressions on low (< 1.0 mg/l), average (1-3 mg/l) and high (> 3 mg/l) were used to analyze the association between antidepressant use and CRP. Results: Antidepressant use was reported by 13% of the adults and the average CRP value for the sample was 4.85 mg/l (SE = 0.0113). 22% had low CRP, 33% had average CRP and 45% had high CRP values. Average CRP values were not statistically different between antidepressant users and non-users. Other factors that were significantly associated with CRP were: perceived health status, smoking and income. For example, adults with excellent perceived health status had significantly lower CRP values (p < 0.004) as compared to those with poor health status. ConClusions: In this population-based study, no statistically significant association between antidepressant use and inflammatory bio-markers were found in individuals with an inflammatory condition. Future research may need to focus on specific inflammatory conditions including depression.

No abstract

No abstract